LY2495655

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY2495655, covering 2018-06-06 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2495655 in Healthy Subjects [Phase 1]